Dachaigh › Myelofibrosis › Washington › Seattle
Sgrùdaidhean clionaigeach Myelofibrosis ann an Seattle, WA
Tha aon sgrùdadh airson Myelofibrosis a’ lorg phàirtichean aig làrach ann no faisg air Seattle. Fosglaidh e gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
A’ fastadhÌre 1/2
- University of Washington - Fred Hutchinson Cancer Center, Seattle
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
A’ fastadhÌre 3
- Fred Hutch Cancer Research, Seattle
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
A’ fastadhÌre 3
- University of Washington, Seattle
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
A’ fastadhÌre 1/2
- University of Washington, Seattle
Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
A’ fastadhÌre 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
A’ fastadhÌre 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
A’ fastadhÌre 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
A’ fastadhÌre 2
- GSK Investigational Site, Seattle
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
A’ fastadhÌre 2
- Fred Hutchinson Cancer Center, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Seattle
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A’ fastadhÌre 3
- Fred Hutchinson Cancer Centre, Seattle
Sgrùdaidhean Myelofibrosis ann am bailtean eile
- Houston, TX19 sgrùdaidhean
- New York City, NY18 sgrùdaidhean
- Boston, MA12 sgrùdaidhean
- Durham, NC12 sgrùdaidhean
- Columbus, OH11 sgrùdadh
- Salt Lake City, UT10 sgrùdaidhean
- Miami, FL10 sgrùdaidhean
- Atlanta, GA9 sgrùdaidhean
- Baldwin Park, CA9 sgrùdaidhean
- Nashville, TN9 sgrùdaidhean
- Tampa, FL9 sgrùdaidhean
- Cleveland, OH9 sgrùdaidhean
Sgrùdaidhean eile ann an Seattle
- Aillse Sgamhain Neo-chealla-beag53 sgrùdaidhean
- Aillse (gach seòrsa)49 sgrùdaidhean
- Aillse Prostata42 sgrùdaidhean
- Leukemia myeloid geur41 sgrùdaidhean
- Aillse a' bhroilleach39 sgrùdaidhean
- Ailse metastatach39 sgrùdaidhean
- Aillse colorectal34 sgrùdaidhean
- Ailseachadh nan Sgamhan33 sgrùdaidhean
- Cancer Ovarian30 sgrùdaidhean
- Myeloma iomaill22 sgrùdaidhean
- Aillse sa bhlaire21 sgrùdaidhean
- Siondròman Myelodysplastic21 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.